Cargando…
Pentoxifylline plus ACEIs/ARBs for proteinuria and kidney function in chronic kidney disease: a meta-analysis
OBJECTIVE: This meta-analysis aimed to investigate the efficacy and safety of pentoxifylline (PTF) plus angiotensin-converting enzyme inhibitors (ACEIs)/angiotensin receptor blockers (ARBs) for proteinuria and kidney function in chronic kidney disease (CKD). METHODS: CENTRAL, EMBASE, Ovid-MEDLINE, P...
Autores principales: | Liu, Dong, Wang, Li-na, Li, Hong-xia, Huang, Ping, Qu, Liang-bo, Chen, Fei-yan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5536675/ https://www.ncbi.nlm.nih.gov/pubmed/28415944 http://dx.doi.org/10.1177/0300060516663094 |
Ejemplares similares
-
Effects of ACEIs Versus ARBs on Proteinuria or Albuminuria in Primary Hypertension: A Meta-Analysis of Randomized Trials
por: Xu, Rui, et al.
Publicado: (2015) -
The Involvement of Chronic Kidney Disease and Acute Kidney Injury in Disease Severity and Mortality in Patients with COVID-19: A Meta-Analysis
por: Wang, Bin, et al.
Publicado: (2020) -
Coronary revascularisation in patients with chronic kidney disease and end‐stage renal disease: A meta‐analysis
por: Li, Xihui, et al.
Publicado: (2021) -
Effects of ACEI and ARB on COVID-19 patients: A meta-analysis
por: Xue, Yang, et al.
Publicado: (2020) -
Administration of ACEI or ARB in chronic kidney disease patients with concomitant SARS-CoV-2 respiratory infection()
por: Mateo Gómez, Cristina, et al.
Publicado: (2021)